Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local Radiotherapy in Synchronous Oligometastatic NSCLC
NCT03119519Phase 2Unknown
- Sponsor
- Southern Medical University
- Start
- Dec 2017
- Primary completion
- Sep 2020
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in non-small cell lung cancer (NSCLC) (2 arms), sponsored by Southern Medical University. Primary endpoint: Progression-free Survival at 5 years. Status: unknown.
02
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT03119519.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03119519.